3rd Quarter - Report

WILLIAMS AND JENSEN, PLLC for PFIZER

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Tax issues affecting the pharmaceutical industry including international tax. H.R. 4213, revenue proposals on international tax.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA New —
KARINA LYNCH —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4213 (111th)

Health Issues HCR

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization act ; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Prescription drug advertising; animal health; and Federal preemption for prescription drugs.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 525 (111th), H.R. 579 (111th), S. 1232 (111th), H.R. 1298 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.